PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23711857-9	2013	RESULTS: Alternaria and polyinosinic-polycytidylic acid (poly I:C) enhanced cell surface expression of MHC class II, CD40, CD80, CD86 and OX40L, and IL-6 production in a concentration-dependent manner.	Poly I-C	24-55	CD86 molecule	Homo sapiens	129-133	
27014268-4	2016	In this article, we show that activation of human BDCA-3 DCs with Poly I:C induces the expression of activation markers (CD40, CD80, and CD86) and immunoglobulin-like transcript (ILT) 3 and 4.	Poly I-C	66-74	CD86 molecule	Homo sapiens	137-141	
26985393-7	2016	For example, either TLR9 ligand, CpG, or TLR3 ligand, poly I:C, was capable of inducing among the highest 10% expression levels of CD86.	Poly I-C	54-62	CD86 molecule	Homo sapiens	131-135	
23711857-9	2013	RESULTS: Alternaria and polyinosinic-polycytidylic acid (poly I:C) enhanced cell surface expression of MHC class II, CD40, CD80, CD86 and OX40L, and IL-6 production in a concentration-dependent manner.	Poly I-C	57-65	CD86 molecule	Homo sapiens	129-133	
22093032-6	2011	These cells respond to both Poly(I:C) and LPS, by up-regulating expression of CD86.	Poly I-C	28-37	CD86 molecule	Homo sapiens	78-82	
35098572-6	2022	CD80 and CD86 were consistently up-regulated in response to cytosolic Poly(I:C) stimulation in all cell types examined and CNA activation also induced robust Type I IFN and low levels of TNFalpha in monocytes, monocyte-derived macrophages, and monocyte-derived dendritic cells.	Poly I-C	70-79	CD86 molecule	Homo sapiens	9-13	
21389871-6	2011	Additional inclusion of polyinosinic: polycytidylic acid during NK-DC cocultures optimized the expression of CD80, CD86, CD40, and HLA-DR on the resulting (NK)DC1, increased their CCR7-mediated migratory responsiveness to the lymph node-associated chemokine CCL21, and further enhanced their IL-12-producing capacity.	Poly I-C	24-56	CD86 molecule	Homo sapiens	115-119	
17963596-7	2007	The rate of CD86 expressions increased after poly I:C stimulation, and the increased rates were 12.6%+/-9.8%, 23.8%+/-20.0%, 20.7%+/-14.3% in the CH group, and 31.0%+/-25.0%, 43.4%+/-24.7%, 44.6%+/-25.5% in the HV group at 12 h, 24 h and 48 h after poly I:C stimulation.	Poly I-C	45-53	CD86 molecule	Homo sapiens	12-16	
17963596-7	2007	The rate of CD86 expressions increased after poly I:C stimulation, and the increased rates were 12.6%+/-9.8%, 23.8%+/-20.0%, 20.7%+/-14.3% in the CH group, and 31.0%+/-25.0%, 43.4%+/-24.7%, 44.6%+/-25.5% in the HV group at 12 h, 24 h and 48 h after poly I:C stimulation.	Poly I-C	249-257	CD86 molecule	Homo sapiens	12-16	
19710456-5	2009	We demonstrated that polyinosinic:polycytidylic acid consistently up-regulated both B7-2 and B7-H1 molecules on resident, migratory DCs from spleen and lymph nodes.	Poly I-C	21-52	CD86 molecule	Homo sapiens	84-88	
17258730-10	2007	Ethanol reduced expression of CD40 and CD86 costimulatory molecules on resting DCs, which was corrected following stimulation with lipopolysaccharide or poly I:C.	Poly I-C	153-161	CD86 molecule	Homo sapiens	39-43	
10384099-5	1999	Poly(I:C)-treated DC show a mature phenotype with high expression levels of HLA-DR, CD86, and the DC maturation marker CD83.	Poly I-C	0-9	CD86 molecule	Homo sapiens	84-88	
31711888-10	2020	Poly(I:C) induced a higher expression of the maturation markers CD80, CD86 and CD40 compared to LPS.	Poly I-C	0-9	CD86 molecule	Homo sapiens	70-74	
33921475-5	2021	We found that co-culture of iDCs with differentially activated LAD2 MCs in serum-containing media significantly modulated polyinosinic:polycytidylic acid (poly I:C)-elicited DC maturation as determined through the surface expression of the maturation markers CD80, CD83, CD86, and human leukocyte antigen(HLA)-DR. Once iDCs were generated in serum-free conditions, they became refractory to the maturation with poly I:C, and the LAD2 MC modulatory potential was minimized.	Poly I-C	155-163	CD86 molecule	Homo sapiens	271-275